Cargando…
Cyclic nucleotide signalling in kidney fibrosis
Kidney fibrosis is an important factor for the progression of kidney diseases, e.g., diabetes mellitus induced kidney failure, glomerulosclerosis and nephritis resulting in chronic kidney disease or end-stage renal disease. Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cG...
Autores principales: | Schinner, Elisabeth, Wetzl, Veronika, Schlossmann, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346839/ https://www.ncbi.nlm.nih.gov/pubmed/25622251 http://dx.doi.org/10.3390/ijms16022320 |
Ejemplares similares
-
Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin
por: Wetzl, Veronika, et al.
Publicado: (2016) -
Antifibrotic function of cGKI in the kidney
por: Schlossmann, Jens, et al.
Publicado: (2015) -
Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015) -
Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017) -
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
por: Schinner, Elisabeth, et al.
Publicado: (2011)